Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors
Cancer cell proliferation may be independent of mTORC1 in acidic conditions.
»
12/05/16
Cancer somatic mutations cluster in a subset of regulatory sites predicted from the ENCODE data
A significantly reduced set of regulatory sites.
»
11/25/16
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
Validation of predicted miR-29b-3p regulation of LAMC1 and PPIC and LASP1.
»
11/16/16
Predicting general and cancer-related distress in women with newly diagnosed breast cancer
Previously anxious women with screen-detected breast cancer at risk of experiencing high levels of cancer-related distress.
»
12/03/16
Analysing population-based cancer survival – settling the controversies
Net survival is the only measure to be used.
»
12/03/16
Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells
3-methyladenine inhibited autophagy and increased cell survival.
»
12/08/16
The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors
Increasing amounts of ERα46 decrease the proliferation rate of MCF7 tumor cells in response to E2.
»
12/07/16
Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
Circulating cell-free DNA concentration increased within 21 days following surgery.
»
12/09/16
Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.
Factors associated with significantly worse OS were older age and elevated CA-125.
»
09/16/16
Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients with Estimated Risk of High Grade Prostate Cancer Less Than or Equal to 10.
Significant improvement in discrimination with the MRI model for biopsy naïve patients.
»
06/06/16
< Prev
Next >